Normothermic Crystalloid Polarizing Cardioplegia Improves Systolic and Diastolic Function in a Porcine Model of Cardiopulmonary Bypass
Previously, we showed that blood-based polarizing cardioplegia exerted beneficial cardioprotection during hypothermic ischemia; however, these positive effects of blood-based polarizing cardioplegia were reduced during normothermic ischemia compared to blood-based hyperkalemic (depolarizing) cardioplegia. This study compares crystalloid polarizing cardioplegia to crystalloid depolarizing cardioplegia in a normothermic porcine model of cardiopulmonary bypass; Methods: Twelve pigs were randomized to receive either normothermic polarizing (<i>n</i> = 7) or depolarizing (<i>n</i> = 5) crystalloid cardioplegia. After the initiation of cardiopulmonary bypass, normothermic arrest (34 °C, 60 min) was followed by 60 min of on-pump and 90 min of off-pump reperfusion. Myocardial injury (arterial CK-MB), hemodynamic function, and the energy status of the hearts were measured; Results: The arterial release of CK-MB was comparable between groups (<i>p</i> = 0.78) during reperfusion. During 150 min of reperfusion, systolic left ventricular pressure (<i>p</i> = 0.01) and coronary flow (<i>p</i> = 0.009) were increased, and wedge pressure (<i>p</i> = 0.04) was decreased in the polarized group. Further hemodynamic parameters (cardiac output, stroke volume) and high-energy phosphate levels were similar between groups. The requirement for noradrenaline administration during reperfusion was significantly higher (<i>p</i> = 0.013) in the polarized group; Conclusions: Under normothermic conditions and despite a similar increase in levels of cardiac CK-MB, crystalloid polarizing cardioplegia protected systolic and diastolic cardiac function after 60 min of cardiac arrest. These results suggest beneficial effects for polarizing cardioplegia; clinical studies are required to confirm these effects.
Authors
- Anne-Margarethe Kramer (ORCID: https://orcid.org/0000-0001-9917-872X)
- Attila Kiss (ORCID: https://orcid.org/0000-0003-4652-1998)
- Seth Hallström (ORCID: https://orcid.org/0000-0002-3160-7388)
- Stefan Heber (ORCID: https://orcid.org/0000-0002-3398-0442)
- David Santer (ORCID: https://orcid.org/0000-0003-4493-4326)
- Bruno Karl Podesser (ORCID: https://orcid.org/0000-0002-4641-7202)
- Judith Radloff
- Katharina Heissl
- David Chambers (ORCID: https://orcid.org/0000-0003-4378-3597)
Institutions
- St Thomas' Hospital (GB)
- King's College London (GB)
- University of Basel (CH)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Medical University of Graz (AT)
- Fachhochschule Wiener Neustadt (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-12-31
- DOI
- https://doi.org/10.3390/biomedicines13010070
- Primary Topic
- Cardiac Ischemia and Reperfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King's College London
- Ludwig Boltzmann Gesellschaft